Two patients with acute promyelocytic leukemia and severe bleeding associated with hypofibrinogenemia were studied. The markedly shortened whole blood clot lysis time and dilute clot lysis time suggested that the defect was an increase in fibrinolysis. Although disseminated intravascular coagulation could not be totally excluded as an alternative mechanism, excessive fibrinolysis was confirmed as the pathogenic cause by the prompt response to the administration of tranexamic acid. The low circulating plasminogen, α 2 plasmin inhibitor level and the presence of α 2 plasmin inhibitor-protease complex in both patients suggested that the increased fibrinolysis probably resulted from the liberation of plasminogen activator from the promyelocyte....
A clinical syndrome characterized by hypo-fibrinogenemia, a coagulation defect, often an associated ...
Plasma levels of fibrinopeptide A (FPA) in 30 untreated patients with acute non-lymphocytic leukemia...
Acute promyelocytic leukaemia (APL) is a disease that is distinguished from other leukaemias by the ...
We present the case of a young man with acute monocytic leukemia (French-American-British classifica...
In order to characterize and compare the variable activation of blood coagulation and fibrinolysis i...
It has been well established that inherited or acquired hypercoagulability is a risk factor for veno...
EssentialsBleeding in chemotherapy induced thrombocytopenia (CIT) might be influenced by hyperfibrin...
Patients with acute promyelocytic leukemia often develop bleeding diatheses during treatment. In sev...
Full list of author information is available at the end of the article(fosfestrol) for prostate canc...
Introduction: Acute promyelocytic leukaemia (APL) (M3) is associated with both a characteristic t(15...
A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation ...
The association between severity of fibrinolysis, ascertained by rotational thromboelastometry to di...
: The most frequent haematological malignancy associated with acquired hypo/dysfibrinogenemia is mul...
DURING the last few years sporadic cases of afibrinogenemia and hypofibrino-genemia have been appear...
The relationship between defective fibrinolysis and arterial thrombosis is uncertain. The evaluation...
A clinical syndrome characterized by hypo-fibrinogenemia, a coagulation defect, often an associated ...
Plasma levels of fibrinopeptide A (FPA) in 30 untreated patients with acute non-lymphocytic leukemia...
Acute promyelocytic leukaemia (APL) is a disease that is distinguished from other leukaemias by the ...
We present the case of a young man with acute monocytic leukemia (French-American-British classifica...
In order to characterize and compare the variable activation of blood coagulation and fibrinolysis i...
It has been well established that inherited or acquired hypercoagulability is a risk factor for veno...
EssentialsBleeding in chemotherapy induced thrombocytopenia (CIT) might be influenced by hyperfibrin...
Patients with acute promyelocytic leukemia often develop bleeding diatheses during treatment. In sev...
Full list of author information is available at the end of the article(fosfestrol) for prostate canc...
Introduction: Acute promyelocytic leukaemia (APL) (M3) is associated with both a characteristic t(15...
A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation ...
The association between severity of fibrinolysis, ascertained by rotational thromboelastometry to di...
: The most frequent haematological malignancy associated with acquired hypo/dysfibrinogenemia is mul...
DURING the last few years sporadic cases of afibrinogenemia and hypofibrino-genemia have been appear...
The relationship between defective fibrinolysis and arterial thrombosis is uncertain. The evaluation...
A clinical syndrome characterized by hypo-fibrinogenemia, a coagulation defect, often an associated ...
Plasma levels of fibrinopeptide A (FPA) in 30 untreated patients with acute non-lymphocytic leukemia...
Acute promyelocytic leukaemia (APL) is a disease that is distinguished from other leukaemias by the ...